^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

PIK3CA mutation

i
Other names: PIK3CA, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, Phosphoinositide-3-kinase, catalytic, alpha polypeptide, Serine/threonine protein kinase PIK3CA, PtdIns-3-kinase subunit P110-alpha, PI3K-alpha, Phosphatidylinositol-4,5-bisphosphate 3-kinase 110 KDa catalytic subunit alpha, Phosphatidylinositol 3-kinase, Catalytic, 110-KD, alpha, PI3-kinase P110 subunit alpha, PI3-kinase subunit alpha, PtdIns-3-kinase subunit alpha, PI3Kalpha, P110alpha, PI3K
Entrez ID:
Related biomarkers:
PIK3CA mutation
HER2 Negative Breast Cancer
alpelisib
Sensitive
:
B
PIK3CA mutation
Breast Cancer
AN2025
Sensitive
:
B
PIK3CA mutation
Breast Cancer
alpelisib
Sensitive
:
B
PIK3CA mutation
Triple Negative Breast Cancer
RG7440
Sensitive
:
B
PIK3CA mutation
Colorectal Cancer
panitumumab
Resistant
:
B
PIK3CA mutation
HER2 Positive Breast Cancer
neratinib
Resistant
:
B
PIK3CA mutation
HER2 Positive Breast Cancer
lapatinib
Resistant
:
B
PIK3CA mutation
HER2 Positive Breast Cancer
trastuzumab
Resistant
:
B
PIK3CA mutation
Colorectal Cancer
atezolizumab + cobimetinib
Sensitive
:
B
PIK3CA mutation
HER2 Positive Breast Cancer
everolimus
Sensitive
:
B
PIK3CA mutation
Non Small Cell Lung Cancer
erlotinib
Resistant
:
B
PIK3CA mutation
Gastric Cancer
alpelisib
Sensitive
:
C2
PIK3CA mutation
HER2 Positive Breast Cancer
trastuzumab + MEN1611
Sensitive
:
C2
PIK3CA mutation
Uterine Cancer
copanlisib
Sensitive
:
C2
PIK3CA mutation
HER2 Positive Breast Cancer
MEN1611
Sensitive
:
C2
PIK3CA mutation
Breast Cancer
palbociclib
Sensitive
:
C2
PIK3CA mutation
Ovarian Cancer
CYH33
Sensitive
:
C2
PIK3CA mutation
Breast Cancer
MEN1611
Sensitive
:
C2
PIK3CA mutation
Breast Cancer
CYH33
Sensitive
:
C2
PIK3CA mutation
Breast Cancer
GDC-0032
Sensitive
:
C2
PIK3CA mutation
Gastric Cancer
AZD5363
Sensitive
:
C2
PIK3CA mutation
Squamous Cell Carcinoma of Head and Neck
alpelisib
Sensitive
:
C2
PIK3CA mutation
Hormone Receptor Positive Breast Cancer
alpelisib
Sensitive
:
C2
PIK3CA mutation
Solid Tumor
copanlisib
Sensitive
:
C2
PIK3CA mutation
Non Small Cell Lung Cancer
U3-1402
Sensitive
:
C3
PIK3CA mutation
Triple Negative Breast Cancer
everolimus
Sensitive
:
C3
PIK3CA mutation
Urothelial Cancer
pembrolizumab
Sensitive
:
C3
PIK3CA mutation
Squamous Cell Carcinoma of Head and Neck
temsirolimus
Sensitive
:
C3
PIK3CA mutation
Non Small Cell Lung Cancer
ensartinib
Resistant
:
C3
PIK3CA mutation
Breast Cancer
bevacizumab
Sensitive
:
C3
PIK3CA mutation
Breast Cancer
ribociclib
Sensitive
:
C3
PIK3CA mutation
Hormone Receptor Positive Breast Cancer
fulvestrant + anastrozole
Sensitive
:
C3